Further mechanistic insights revealed the down-regulation of HDAC2 and HDAC3 and enhanced levels of H3K4Me3 (trimethylated lysine 4 of histone 3) in the promoter region of p21 in both breast cancer cell lines [88]. This evidence concerns the gene HDAC2 and breast carcinoma.